3,881
edits
Changes
Jump to navigation
Jump to search
Line 1,093:
Line 1,093: − + − + − + − + − + Line 1,109:
Line 1,109: − + − + − + − + − + Line 1,125:
Line 1,125: − + − + − + − + − + Line 1,141:
Line 1,141: − + − + − + − + − + Line 1,157:
Line 1,157: − + − + − + − +
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 12:42, 20 December 2023
, 12:42, 20 December 2023no edit summary
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|IgG4-related disease
|IgG4-related disease
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Unicentric Castleman disease
|Unicentric Castleman disease
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Idiopathic multicentric Castleman disease
|Idiopathic multicentric Castleman disease
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|KSHV/HHV8-associated multicentric Castleman disease
|KSHV/HHV8-associated multicentric Castleman disease
|
|
|
|
|
|Multicentric Castleman Disease
|Sudha Arumugam, MD
|Sudha Arumugam, MD
|
|Complete
|
|01/24/2022
|
|Date completed by author: 01/24/2022
|-
|-
|B-lymphoblastic leukaemia/lymphoma
|B-lymphoblastic leukaemia/lymphoma